Liver International

O tempora, o mores cancrorum
pp. 153-154(2)
Author: Dufour, J.-F.

T regulatory cells and autoimmune liver disease
pp. 155-157(3)
Authors: Hirschfield, Gideon M.; Heathcote, Jenny

How to be a great reviewer: an editor's view
pp. 158-159(2)
Author: Lee, Samuel S.

Molecular pathogenesis of hepatocellular carcinoma
pp. 160-174(15)
Authors: Wong, Chun-Ming; Ng, Irene O. L.

Viral hepatocarcinogenesis: from infection to cancer
pp. 175-188(14)
Authors: Tan, Alexander; Yeh, Shiou-Hwie; Liu, Chun-Jen; Cheung, Claudia; Chen, Pei-Jer

Radiological diagnosis of hepatocellular carcinoma
pp. 189-199(11)
Authors: Saar, B.; Kellner-Weldon, F.

Protective effect of Kalpaamruthaa in combating the oxidative stress posed by aflatoxin B₁-induced hepatocellular carcinoma with special reference to flavonoid structure-activity relationship
pp. 200-213(14)
Authors: Umarani, Mohanasundaram; Shanthi, Palanivelu; Sachdanandam, Panchanadham

New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needle
pp. 214-219(6)
Authors: Hirakawa, Miharu; Ikeda, Kenji; Kawamura, Yusuke; Kobayashi, Masahiro; Hosaka, Tetsuya; Yatsuji, Hiromi; Sezaki, Hitomi; Akuta, Norio; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Saitoh, Satoshi; Arase, Yasuji; Kumada, Hiromitsu

Evaluation of hepatotropic targeting properties of allogenic and xenogenic erythrocyte ghosts in normal and liver-injured rats
pp. 220-232(13)
Authors: Gressner, Olav A.; Lahme, Birgit; Koch, Martin; Gressner, Axel M.

Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis
pp. 233-239(7)
Authors: Liu, Bin; Shi, Xu Hua; Zhang, Feng Chun; Zhang, Wen; Gao, Li Xia

Transjugular intrahepatic portosystemic shunts in liver transplant recipients
pp. 240-248(9)
Authors: Kim, John J.; Dasika, Narasimham L.; Yu, Esther; Fontana, Robert J.

Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome
pp. 249-256(8)
Authors: Murad, Sarwa Darwish; Luong, Trinh K.; Pattynama, Peter M. T.; Hansen, Bettina E.; van Buuren, Henk R.; Janssen, Harry L. A.

Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C
pp. 257-263(7)
Authors: Toniutto, Pierluigi; Fabris, Carlo; Falleti, Edmondo; Cussigh, Annarosa; Fontanini, Elisabetta; Bitetto, Davide; Fornasiere, Ezio; Minisini, Rosalba; De Feo, Tullia; Marangoni, Francesca; Pirisi, Mario

Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease
pp. 264-270(7)
Authors: Hoevenaren, Inge A.; Wester, Ruth; Schrier, Robert W.; McFann, Kim; Doctor, R. Brian; Drenth, Joost P. H.; Everson, Gregory T.

High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
pp. 271-277(7)
Authors: Hsu, Ching-Sheng; Liu, Chun-Jen; Liu, Chen-Hua; Wang, Chia-Chi; Chen, Chi-Ling; Lai, Ming-Yang; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn

Anabolic-androgenic steroids and liver injury
pp. 278-282(5)
Authors: Sánchez-Osorio, Magdalena; Duarte-Rojo, Andrés; Martínez-Benítez, Braulio; Torre, Aldo; Uribe, Misael

`Liver: an alarm for the heart?'
pp. 283-283(1)
Author: Alavian, Seyed-Moayed

Reply:
pp. 284-285(2)
Authors: Mirbagheri, Seyed Amir; Rashidi, Armin; Abouzari, Mehdi

Comparison of health-related quality of life between populations
pp. 285-286(2)
Authors: Slavenburg, Serena; van Oijen, Martijn G.H.; Spiegel, Brennan M.R.

Reply:
pp. 286-287(2)
Authors: Dan, Amy; Younossi, Zobair

Corrigendum
pp. 288-288(1)

Announcements
pp. 289-289(1)